Stockreport

CollPlant and United Therapeutics ink deal for 3D bioprinting of solid-organ scaffolds for human transplants; CLGN up 37% premarket [Seeking Alpha]

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation
PDF CollPlant and United Therapeutics ink deal for 3D bioprinting of solid-organ scaffolds for human transplants; CLGN up 37% premarket [Read more]